Urine biopsy offers a more accurate way to detect bladder, kidney and prostate cancers
A 2026 study in Singapore reveals that urine liquid biopsy is a highly effective, non-invasive method for detecting bladder, kidney, and prostate cancers. By analyzing genetic fragments like DNA and RNA in urine, this method offers higher accuracy than traditional cytology.
Using an emerging urine test on a sample like this can detect bladder, kidney and prostate cancers more accurately, a study found. SINGAPORE – An emerging urine test has proved to be more accurate than conventional methods in detecting bladder and prostate cancers, while providing patients with a less painful and invasive screening option for prostate and kidney cancers.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in